Antisecretory Factor 16 (AF16): A Promising Avenue for the Treatment of Traumatic Brain Injury—An In Vitro Model Approach
Journal of Molecular Neuroscience · 2024
DOI: 10.1007/s12031-024-02268-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Neuroscience, 2024. Verfasst von Nicola Vahrmeijer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiological Sciences, Stellenbosch University, Merriman Avenue, Mike de Vries Building, Stellenbosch, 7600, South Africa. Hauptthemen laut MEDLINE: Autophagy, Brain Injuries, Traumatic. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stellenbosch University.
Abstract (Originalsprache)
Traumatic brain injury (TBI) is caused by an external mechanical force to the head, resulting in abnormal brain functioning and clinical manifestations. Antisecretory factor (AF16) is a potential therapeutic agent for TBI treatment due to its ability to inhibit fluid secretion and decrease inflammation, intracranial pressure, and interstitial fluid build-up, key hallmarks presented in TBI. Here, we investigated the effect of AF16 in an in vitro model of neuronal injury, as well as its impact on key components of the autophagy pathway and mitochondrial dynamics. N2A wt cells were treated with AF16, injured using a scratch assay, and analysed using confocal microscopy, correlative light and electron microscopy (CLEM), flow cytometry, and western blotting. Our results reveal that AF16 enhances autophagy activity, regulates mitochondrial dynamics, and provides protection as early as 6 h post-injury. Fluorescently labelled AF16 was observed to localise to lysosomes and the autophagy compartment, suggesting a role for autophagy and mitochondrial quality control in conferring AF16-associated neuronal protection. This study concludes that AF16 has potential as a therapeutic agent for TBI treatment through is regulation of autophagy and mitochondrial dynamics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiological Sciences, Stellenbosch University, Merriman Avenue, Mike de Vries Building, Stellenbosch, 7600, South Africa.
- Central Analytical Facilities, Stellenbosch University, Tygerberg Medical Campus, Clinical Building, 7Th Floor, Room 7063, Stellenbosch, South Africa.
- Department of Neurosurgery, Tygerberg University Hospital, Tygerberg, Cape Town, South Africa.
- Division Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
- Central Analytical Facilities, Stellenbosch University, Merriman Avenue, Mike de Vries Building, Stellenbosch, 7600, South Africa.
- Department of Physiological Sciences, Stellenbosch University, Merriman Avenue, Mike de Vries Building, Stellenbosch, 7600, South Africa. bloos@sun.ac.za.
Förderung
- Stellenbosch University
Zitieren
APA
Vahrmeijer, N., Kriel, J., Harrington, B. M., van Staden, A. D. P., Vlok, A. J., Engelbrecht, L., Du Toit, A., & Loos, B. (2024). Antisecretory Factor 16 (AF16): A Promising Avenue for the Treatment of Traumatic Brain Injury—An In Vitro Model Approach. Journal of Molecular Neuroscience. https://doi.org/10.1007/s12031-024-02268-6
Vancouver
Vahrmeijer N, Kriel J, Harrington BM, van Staden ADP, Vlok AJ, Engelbrecht L, et al. Antisecretory Factor 16 (AF16): A Promising Avenue for the Treatment of Traumatic Brain Injury—An In Vitro Model Approach. Journal of Molecular Neuroscience. 2024. doi:10.1007/s12031-024-02268-6
BibTeX
@article{Vahrmeijer2024,
author = {Vahrmeijer, Nicola and Kriel, Jurgen and Harrington, Bradley M and van Staden, Anton Du Preez and Vlok, Adriaan Johannes and Engelbrecht, Lize and Du Toit, Andre and Loos, Ben},
title = {Antisecretory Factor 16 (AF16): A Promising Avenue for the Treatment of Traumatic Brain Injury—An In Vitro Model Approach},
journal = {Journal of Molecular Neuroscience},
year = {2024},
doi = {10.1007/s12031-024-02268-6}
}
EUVIMED